Press Releases

  • All
  • Press Release 2022
  • Press Release 2023
  • Press Releases 2009
  • Press Releases 2010
  • Press Releases 2011
  • Press Releases 2012
  • Press Releases 2014
  • Press Releases 2017
  • Press Releases 2018
  • Press Releases 2019
  • Press Releases 2020
  • Press Releases 2021

«Lavipharm SA, in compliance with the requirement under Article 4.1.4.3.1 of the Athens Stock Exchange Rulebook, hereby releases its Financial Calendar for the year 2022 : Announcement of the 2021 Annual Financial Accounts: Monday, March 21st, 2022 Analysts’ FY 2021 conference call : Friday, April...

Paiania, January 18, 2022 - Lavipharm SA, in the context of its obligations in accordance with the provisions of Law 4706/2020 on Corporate Governance and the decision No. 3/347/12.07.2005 of the Hellenic Capital Market Commission’s Board of Directors, informs the investors’ community that, following the...

Paiania, 22 November 2021 - Lavipharm S.A. announces, in accordance with Regulation 596/2014 / EU and the Regulation of the Athens Stock Exchange, each as in force, that Mr. Vassilis Baloumis assumes the duties of Chief Financial Officer on December 1, 2021 replacing Mr. Spyridon...

Peania, November 12, 2021 - Lavipharm participated in CPhI Worldwide 2021, the largest exhibition in the pharmaceutical industry worldwide, uniting thousands of pharma suppliers and buyers across the full supply chain from around the world. The event took place in Milan from 9 to 11...

Παιανία, 25 Αυγούστου 2021 – Η Lavipharm εκφράζει τη βαθύτατη θλίψη της για τον πρόωρο θάνατο της Λητούς Νίκης Ιωαννίδου το Σάββατο, 21 Αυγούστου 2021. Η Λητώ Ιωαννίδου διετέλεσε Μέλος του Διοικητικού Συμβουλίου της Lavipharm A.E. από το 2008 και Πρόεδρος της Επιτροπής Ελέγχου μέχρι την...

Peania, May 10th 2021 - It is with great sadness that the family of Lavipharm bids farewell to Athanase (Thanassis) Lavidas, Executive Chairman, who passed away on Saturday, May 8, 2021, at the age of 73. Athanase Lavidas was Lavipharm’s majority shareholder leading the company since 1976. Under...

[video width="960" height="540" mp4="https://lavipharm.com/wp-content/uploads/2020/12/2021.mp4" poster="https://lavipharm.com/wp-content/uploads/2020/12/lavipharm2021.jpg"][/video]...

Παιανία, 30 Νοεμβρίου 2020 – Η Lavipharm A.E., σε συνέχεια επιστολής της Επιτροπής Κεφαλαιαγοράς με αριθμό πρωτοκόλλου 2503/18.11.2020 η οποία κοινοποιήθηκε σε όλους τους εκδότες με κινητές αξίες εισηγμένες προς διαπραγμάτευση στη ρυθμιζόμενη αγορά του Χρηματιστηρίου Αθηνών, ενημερώνει το επενδυτικό κοινό για τα βασικά οικονομικά...

Peania, August 21st, 2020 – Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.’s Executive Chairman, Dr. Athanase...